Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06487364

Determination of the Minimal Detectable Change of the Parkinson's Disease Questionnaire-8

Determination of the Minimal Detectable Change and Minimum Clinically Important Change Score of the Parkinson's Disease Questionnaire-8

Status
Recruiting
Phase
Study type
Observational
Enrollment
39 (estimated)
Sponsor
Emre Şenocak · Academic / Other
Sex
All
Age
40 Years – 80 Years
Healthy volunteers
Not accepted

Summary

This study is conducted to determine how many units of improvement the Parkinson's Disease Questionnaire-8 (PDQ-8), used to evaluate the quality of life of Parkinson's patients, should have to express a significant change in the quality of life. Patients for whom a 30-session physiotherapy program is recommended will be included in the study. Patients will be asked to express the change in their quality of life at the end of treatment. The PDQ-8 survey and Global Rating of Patient-Perceived Changes (GRP-PC) forms will be used to determine these changes. Evaluations will be repeated at the beginning of the treatment program and at the end of the 30th session.

Conditions

Interventions

TypeNameDescription
OTHERRehabilitationA routine physical therapy program prescribed by a specialist physician and physiotherapist will be applied.

Timeline

Start date
2024-05-13
Primary completion
2025-01-17
Completion
2025-09-17
First posted
2024-07-05
Last updated
2025-03-05

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT06487364. Inclusion in this directory is not an endorsement.